Northwest Biotherapeutics reported $239.4M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Infinity Pharmaceuticals USD 0 0 Apr/2026
Merck USD 261.26B 51.62B Dec/2025
Northwest Biotherapeutics USD 246M 110M Apr/2026
Pfizer USD 141.57B 6.48B Dec/2025
Plus Therapeutics USD 17M 54M Apr/2026
Roche Holding CHF 266.34B 55.46B Dec/2025